Answers are grounded in this paper and cite their sources.
Alastair Matheson describes how the pharmaceutical publications industry seeks to legitimise ghostwriting by changing its definition while deflecting attention from wider marketing practices in academic publishing
No takes yet. Share an insight, caveat, or question.
Alastair Matheson (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: